Quality of life drastically improved by LASIK

Article

Femtosecond laser-assisted LASIK significantly improves refractive error-related quality of life (QOL) in myopic patients

Femtosecond laser-assisted LASIK significantly improves refractive error-related quality of life (QOL) in myopic patients, claims a study in the Journal of Refractive Surgery.

Dr Alexandra Meidani et al., Center of Health Services Research, Dept of Hygiene, Epidemiology and Medical Statistics Medical School, University of Athen, Athens, Greece, used the Quality of Life Impact of Refractive Correction (QIRC) questionnaire to assess QOL in 190 myopic patients.

Of the patients included in the investigation, 95 underwent LASIK with femtosecond laser flap creation and ablation. The Rasch analysis was used to score the questionnaire and validity was evaluated by internal consistency reliability, repeatability by intraclass correlation coefficient (ICC) and Bland-Altman limits of agreement.

Preoperatively the total QIRC score was a mean of 38.9±5.7. This improved to 53.7±5.1 postoperatively. The QIRC score was greater for contact lens wearers compared to spectacle wearers. Inter-item correlations ranged from 0.32 to 0.79 and repeatability was significantly high with Bland-Altman limits of agreement at −6.72 to +5.41.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.